leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 13:14:08 - browse：92

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Medicare has a new plan to address drug shortages

knowledge

WSS

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Why hospitals are withdrawing from US News rankings

Senate HELP committee spars over health care workforce policies

Second xenotransplant done with gene

At Orexo, a ‘turning point’ for everything but digital health

CommonSpirit Health keeps growing, even as it loses money

entertainment

leisure time

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

It's been 20 years since Dolly the sheep. Where's my clone?

Malaria cases in Florida and Texas: Here’s what you need to know

Google and Epic fight stronger regulation of AI in health care

Wildfire smoke exposes gaps in outdoor worker protections

Google and Epic fight stronger regulation of AI in health care

Affirmative action in medical school literally saved lives

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

New air purifier tech could be key to improving indoor air quality

Microbiome research is starting to find links to chronic diseases

hotspot

Listen: Wegovy in the brain & pivotal Alzheimer's data

Hearing on Medicare drug price negotiation gets unusually heated

FDA approves RSV monoclonal antibody for infants, toddlers

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

How Medicaid coverage policies for immigrants impact new moms

FDA panel to weigh approval of NurOwn, controversial ALS drug

leisure time

knowledge

knowledge

Wikipedia